312
Participants
Start Date
June 30, 2016
Primary Completion Date
January 31, 2018
Study Completion Date
January 31, 2018
P03277
Single intravenous (IV) bolus injection at a rate of 2 mL/second
Gadobenate dimeglumine
Single IV bolus injection at a rate of 2 mL/second
MRI
Penn State milton S. Hershey Medical center, Hershey
University of Pensylvania medical center, Philadelphia
Temple university hospital, Philadelphia
Medical University of South Carolina, Charleston
QUEST Research Institute, Farmington Hills
Northwestern memorial hospital, Chicago
University of texas McGovern medical school, Houston
University of Washington, Seattle
Beth israel deaconess medical center, Boston
Rhode Island hospital, Providence
ZNA campus Middelheim, Antwerp
Universitair Ziekenhuis Brussel, Brussels
Fakultni nemocnice Olomouc, Olomouc
Neurology Clinic-Semmelweis Medical University, Budapest
Pecsi Tudomany Egyetem Klinikai kozpont Idegsebeszeti Klinica, Pécs
Ospedali Riuniti di Ancona, Ancona
Ospedale san Raffaele, Milan
AO S. Andrea Universita La Sapienza, Roma
Azienda policlinico Umberto, Roma
Centro medico ABC santa fe, Mexico City
Axis heilsa, Monterrey
Clinical research institute SC, Tlalnepantla
Centrum Onkologii Instytut im. Marii Sklodowskiej-Curie, Oddzial w Gliwicach, Gliwice
krakowski Szpital specjalistyczny il Jana Pawla II, Krakow
Samodzielny publiczny szpital, Lublin
Asan medical center, Seoul
Samsung medical center, Seoul
Seoul National university hospital, Seoul
Lead Sponsor
Guerbet
INDUSTRY